Literature DB >> 6148164

Specific inhibition of aldosterone responses to endogenous and exogenous angiotensin II by somatostatin.

C R Jones, J A Millar, C Lawrie, D J Sumner, J L Reid.   

Abstract

Aldosterone and renin responses to head-up tilt (60 degrees for 1 h) and angiotensin II infusions (2,5 and 10 ng/kg/min) 1 h later were compared in six normal subjects during infusions of somatostatin (3 micrograms/kg/min) or saline. The infusions were performed on separate days two weeks apart. The increase in aldosterone due to exogenous angiotensin II and orthostasis were significantly attenuated by somatostatin. Neither the increase in plasma renin activity (PRA) nor the angiotensin II mediated suppression of PRA were affected by somatostatin. These findings are consistent with the recent observation that somatostatin suppresses aldosterone release in response to angiotensin II in rat adrenal cells in culture and they indicate a possible role for somatostatin in the regulation of aldosterone secretion.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6148164     DOI: 10.1111/j.1365-2265.1984.tb03470.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  2 in total

1.  Expression of somatostatin and somatostatin receptor subtypes 1-5 in human normal and diseased kidney.

Authors:  Sunil Bhandari; Neil Watson; Ervine Long; Steve Sharpe; Wenwen Zhong; Shang-Zhong Xu; Stephen L Atkin
Journal:  J Histochem Cytochem       Date:  2008-04-28       Impact factor: 2.479

2.  Somatostatin in renal physiology and autosomal dominant polycystic kidney disease.

Authors:  A Lianne Messchendorp; Niek F Casteleijn; Esther Meijer; Ron T Gansevoort
Journal:  Nephrol Dial Transplant       Date:  2020-08-01       Impact factor: 5.992

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.